FNC-TP trisodium Catalog No.:M16383-C no significant inhibition is observed

no significant inhibition is observed in MM

Cevimeline has also been shown to reduce Xerostomia symptoms and increase salivary flow in head and neck cancer survivors after radiotherapy

SGN-CD33A can kill MDR1 expressing CD33 positive AML patient samples and is currently in Phase I

0b013e32835566c0

Lopac-D-0540

FNC-TP trisodium Catalog No.:M16383-C no significant inhibition is observedFNC TP trisodium is the intracellular active form of FNC. FNC is a potent nucleoside reverse transcriptase inhibitor (NRTI), with antiviral activity on HIV, HBV and HCV. Product information Molecular Weight: 592. 11 Formula: C9H11FN6Na3O13P3 Chemical Name: sodium ((2R, 3R, 4S, 5R) 5 (4 amino 2 oxopyrimidin 1(2H) yl) 2 azido 4 fluoro 3 hydroxytetrahydrofuran 2 yl)methyl hydrogen triphosphate Smiles: [N